This message contains images. If you don't see images, click here to view. Click
here to advertise in this news brief.
|
|
|
|
The association of center performance evaluations and kidney transplant volume in the US
American Journal of Transplantation (subscription required)
Share
  
Report cards evaluating transplant center performance have received significant attention in recent years corresponding with the Centers for Medicare and Medicaid Services issue of the 2007 Conditions of Participation. The primary aim was to evaluate the association of report card evaluations with transplant center volume. Researchers utilized data from the Scientific Registry of Transplant Recipients (SRTR) along with six consecutive program-specific reports from January 2007 to July 2009 for adult kidney transplant centers. Among 203 centers, 46 (23 percent) were low performing with statistically significantly lower than expected 1-year graft or patient survival at least once during the study period.
More
 |
• We are an FDA licensed manufacturer.
• We label peptides, monoclonal antibodies, reagents, chemical and proteins for cancer treatments.
• Our above products can be labeled with radioisotopes such as I-125, I-131, P32, Tc99m, Y90 and AC-225. • We have a multicurie isotope license and an animal facility.
|
Register now for CEOT
AST
Share
  
The first annual Cutting Edge of Transplantation (CEOT) meeting is right around the corner. Register now to take advantage of the buy one registration, get one half off deal. Join the experts from Feb. 14-16 in Scottsdale, Ariz., to discuss controversies and challenges related to B cells and antibodies in transplantation. Learn more about this informative meeting by reading the latest Speaker Spotlight, and then register with your colleagues.
 |
Identify Antibodies That May Compromise Graft Survival
- Detect Presence of Complement Fixing Antibodies
- Investigate risk of developing Antibody Mediated Rejection (AMR)
Request a Complimentary Sample Kit! FREE SAMPLE
For Research Use Only. Not for use in diagnostic procedures.
|
Antibody Mediated Rejection in Liver Transplantation meeting March 2013 in Dallas
AST
Share
  
Antibody mediated rejection is a well known and feared entity in all solid organ transplants – except the liver. Previous studies and literature regarding liver allografts have been inconsistent, and mounting evidence has shown the pathologic potential of DSA in liver and SLKT recipients. The goal of this conference is to bring about a meeting of the minds to define AMR in liver transplantation and forge a path for future research in this burgeoning area of research. Program information is available at www.DallasAMR.com. To register visit https://www.regonline.com/DallasAMR.
Study: Most living donors would do it again
Renal & Urology News
Share
  
A German study found that living kidney donation is safe and most donors report that they would donate again. Still, a small percentage of living kidney donors may experience physical or mental discomforts following donation. Researchers studied 128 living kidney donors and found that less than 10 percent of them reported impaired quality of life directly related to kidney donation.
More
The relationship of socio-demographic factors and satisfaction with social support at 5, 10 years after heart transplantation
American Journal of Transplantation (subscription required)
Share
  
Despite the fact that social support has been found to be important to cardiovascular health, there is a paucity of information regarding the relationship between social support and outcomes long term after heart transplantation (HT). The purposes of a recent study were to examine demographic and psychosocial characteristics and their relationship to social support after HT and to identify whether socio-demographic variables are predictors of satisfaction with social support post-HT.
More
Transplanted genetically-modified adipose cells offer potential therapy for liver diseases
Medpage Today
Share
  
Using mesenchymal stromal cells derived from adipose (fat) tissues, genetically modified to express a bioluminescent marker, researchers in Italy have tracked cells after transplantation. The cells were followed from their injection into the spleen of mice modeling liver disease, to their characterization as "hepatic precursors," and to their subsequent migration through the spleen before engrafting at regenerating sites in the liver by bioluminescent imaging.
More
|
|
|
|
 |
|
Genetic testing can be a cost-effective way to increase the number of living related donor transplants. Mutational analysis may help direct long-term treatment plans, including pre-operative screening of potential kidney transplant recipients and living related donors.
|
|
|
|
 |
|
✓ Hypothermic preservation of a single kidney using physiologic pulsatile preservation and membrane oxygenation: a proven technology from Waters Medical Systems (more than 40 years clinical experience)
✓ Simplifies the perfusion process (provides more options to view, chart, and trend data, offers web-based remote monitoring, and a transportable design)
✓ Meets or exceeds current FDA standards and AOPO and UNOS Preservation Guidelines.
|
|
|
|
 |
|
When it comes to saving lives, MNX understands organ transplant logistics. Every shipment is urgent, and every step critical. That’s why MNX offers specialty services that are tailored for organ transportation. From expedited ground service to charter flights, MNX has the proven experience and operational resources you can count on.
|
|
Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death
Liver Transplantation (subscription required)
Share
  
Worsening donor liver quality resulting in decreased organ utilization may be contributing to the recent decline in liver transplants nationally. Researchers conducted a study to examine trends in donor liver utilization and the relationship between donor characteristics and nonuse. The United Network for Organ Sharing database was used to to review all deceased adult organ donors in the United States from whom at least one solid organ was transplanted into a recipient.
More
Study: Iron oxide nanoparticles effective for labeling human endothelial cells
Medical News Today
Share
  
A team of researchers from three medical institutions in Guangzhou, China, have found that iron oxide nanoparticles (INOPS) are a useful contrast agent for in vivo magnetic resonance tracking of transplanted human endothelial cells. However, the impact of INOPS on the cells varies with a number of factors including the INOPS load. They found that the percentage of iron-labeled cells was significantly lower after 48 hours post-transplantation than at 24 hours post-transplantation. They also found that high INOPS concentration can affect cell activity. High INOPS concentration can induce cell death (apoptosis).
More
Low-dose valacyclovir effective for cytomegalovirus prophylaxis
Renal & Urology News
Share
  
Low-dose valacyclovir prophylaxis reduces the incidence of cytomegalovirus (CMV) disease in CMV-negative renal transplant recipients who receive a renal allograft from a CMV-infected donor, new findings suggest. It also results in high patient and graft survival rates.
More
|
|
|
To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact James DeBois at 469-420-2618.
MORE
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|